Oxidation dyeing composition for keratinous fibres and dyeing method using same

ABSTRACT

The invention concerns an oxidation dyeing composition for keratinous fibers, and in particular for human keratinous fibers such as hair comprising, in a suitable dyeing medium, at least an oxidation base selected among certain substituted paraphenylenediamine derivatives and their addition salts with an acid, and at least a selected coupling agent, and the dyeing method using said composition.

[0001] A subject-matter of the invention is a composition for the oxidation dyeing of keratinous fibres and in particular of human keratinous fibres, such as the hair, comprising, in a medium appropriate for dyeing, at least one oxidation base chosen from certain substituted para-phenylenediamine derivatives and their addition salts with an acid and at least one selected coupler, and the dyeing process employing this composition.

[0002] It is known to dye keratinous fibres and in particular human hair with dyeing compositions comprising oxidation dye precursors, in particular ortho- or para-phenylenediamines, ortho- or para-aminophenols or heterocyclic bases, generally known as oxidation bases. Oxidation dye precursors or oxidation bases are colourless or weakly coloured compounds which, in combination with oxidizing substances, can give rise by an oxidative coupling process to coloured and colouring compounds.

[0003] It is also known that the shades obtained with these oxidation bases can be varied by combining them with couplers or colouring modifiers, the latter being chosen in particular from aromatic meta-diamines, meta-aminophenols, meta-diphenols and certain heterocyclic compounds.

[0004] The variety of the molecules employed as oxidation bases and couplers makes it possible to obtain a rich palette of colours.

[0005] The so-called “permanent” colouring obtained by virtue of these oxidation dyes has, however, to satisfy a certain number of requirements. Thus, it must make it possible to obtain shades with a desired intensity and behave well in the face of external agents (light, bad weather, washing, permanent waving, perspiration or rubbing).

[0006] The dyes must also make it possible to cover white hair and, finally, be as unselective as possible, that is to say make it possible to obtain the least possible differences in colouring along the same keratinous fibre, this being because the latter can be sensitized (i.e. damaged) to a varying degree between its tip and its root.

[0007] Provision has already been made, in particular in Patent Applications JP-11158046, JP-11158047 and JP-11158048, for compositions for the oxidation dyeing of keratinous fibres comprising, as oxidation dye precursors, certain substituted para-phenylenediamine derivatives. However, the colourings obtained on employing these compositions are not always powerful enough, chromatic enough or sufficiently resistant to the various attacks which the hair may be subjected to.

[0008] In point of fact, the Applicant Company has now just discovered that it is possible to obtain novel dyes, which dyes are capable of resulting in colourings with varied shades which are chromatic, powerful, attractive, not very selective and highly resistant to the various attacks which the fibres may be subjected to, by combining at least one oxidation base chosen from certain para-phenylenediamine derivatives of formula (I) defined below and their addition salts with an acid and at least one suitably selected coupler.

[0009] This discovery forms the basis of the present invention.

[0010] A first subject-matter of the invention is thus a composition for the oxidation dyeing of keratinous fibres and in particular of human keratinous fibres, such as the hair, characterized in that it comprises, in a medium appropriate for dyeing:

[0011] at least one oxidation base chosen from substituted para-phenylenediamine derivatives of following formula (I) and their addition salts with an acid:

[0012] in which;

[0013] R₁ and R₂ can take one of the following meanings i) to v):

[0014] i) R₁ and R₂ simultaneously represent a —(CH₂)₂CHOHCH₂OH radical; or

[0015] ii) R₁ represents a —CH₂(CHOH)₄CH₂OH radical and R₂ represents a hydrogen atom, an alkyl or aryl radical or a heterocycle; or

[0016] iii) R₁ represents an alkyl or aryl radical or a heterocycle and R₂ represents an alkylene radical —(CH₂)_(m)— in which m is an integer equal to 2 or to 3, the said alkylene radical forming a ring in conjunction with the nitrogen atom, the carbon atom of the benzene ring carrying the nitrogen atom and one of the two carbon atoms of the benzene ring which are adjacent to it, it being understood that, when R₁ is an alkyl or aryl radical, then either R₁ or the said alkylene radical is substituted by a radical comprising at least one nitrogen, oxygen or sulphur atom;

[0017] iv) R₁ represents a —(CH₂CH₂O)_(p)R₄ radical in which p is an integer between 2 and 8 inclusive and R₄ and R₂, which are identical or different, represent a hydrogen atom, an alkyl or aryl radical or a heterocycle;

[0018] v) R₁ and R₂ form, in conjunction with the nitrogen atom to which they are attached, a saturated 5-, 6- or 7-membered heterocycle, the said heterocycle being substituted by at least one radical comprising at least one carbon, nitrogen, oxygen or sulphur atom;

[0019] R₃ represents a halogen atom, an alkyl or aryl radical, a heterocycle, a heterocycle connected to the benzene ring of the formula (I) via an ether or sulphide bond, or a cyano, nitro, hydroxyl, carboxyl, sulpho, alkoxy, aryloxy, cyanoamino, amino, anilino, ureido, sulphamoyl, mono- or dialkyl-sulphamylamino, alkylthlo, arylthio, alkoxycarbonylamino, sulphonamido, carbamyl, mono- or dialkylcarbamylsulphamyl, alkylsulphonyl, alkoxycarbonyl, azo, acyloxy, carbamyloxy, mono- or dialkyl-carbamyloxy, silyl, silyloxy, aryloxycarbonylamino, imido, sulphinyl, phosphonyl, aryloxycarbonyl, acyl or mercapto radical; the said alkyl radicals comprising from 1 to 25 carbon atoms and being able to be linear, branched or cyclic and to be substituted by one or more radicals and then to represent a mono- or polyhydroxyalkyl, alkoxyalkyl, aminoalkyl, optionally substituted on the nitrogen atom, carboxyalkyl, alkylcarboxyalkyl, thioalkyl, alkylthioalkyl, cyanoalkyl, trifluoroalkyl, sulphoalkyl, phosphoalkyl or haloalkyl radical; the said alkoxy radicals comprising from 1 to 25 carbon atoms and being able to be linear, branched or cyclic; the said aryl radicals comprising from 6 to 26 carbon atoms and being able to be substituted by one or more radicals chosen from alkyl, substituted alkyl or alkoxy radicals;

[0020] the heterocycles being mono- or polycyclic, each ring comprising 3, 4, 5 or 6 ring members and being able to comprise one or more heteroatoms, it being understood that, in the case of polycyclic heterocycles, at least one of the rings comprises at least one heteroatom such as N, O or S;

[0021] n is an integer between 0 and 4; it being understood that, when n is greater than 1, then the R₃ radicals can be identical or different and can form, with one another, a saturated or unsaturated 3-, 4-, 5- or 6-membered ring;

[0022] with the proviso that:

[0023] 1) when R₁ and R₂ have the meanings defined in point v), then the compounds of formula (I) do not comprise more than 3 hydroxyl radicals;

[0024] 2) when R₁ and R₂ have the meanings defined in point v) and when R1 and R₂ form a pyrrolidine ring substituted by a carbamoyl radical on the carbon in the position a to the nitrogen atom to which they are attached, then n is other than 0; or else the pyrrolidine ring carries at least two substituents;

[0025] 3) when R₁ and R2 have the meanings defined in point v) and when R₁ and R₂ form a pyrrolidine ring substituted by a hydroxymethyl radical on the carbon situated in the a position with respect to the nitrogen atom to which they are attached and when n=0 or 1, then either the said ring carries at least two additional substituents or the said ring comprises only one second substituent other than a hydroxyl radical on the carbon situated in the β position with respect to the nitrogen atom and with respect to the carbon carrying the said hydroxymethyl substituent; or else, when R₁ and R₂ have the meanings defined in point v) and R₁ and R₂ form a pyrrolidine ring substituted by a hydroxymethyl radical on the carbon situated in the α position with respect to the nitrogen atom to which they are attached and when n=1, then R₃ is other than an alkyl or mono- or polyhydroxyalkyl radical;

[0026] 4) when R₁ and R₂ have the meanings defined in point iii), the compounds of formula (I) must fulfil at least one of the following four conditions:

[0027] a) whatever the value of n, the alkylene ring formed by the R₂ radical comprises a substituent in addition to the R₁ radical; or

[0028] b) n is greater than 1; or

[0029] c) when n is equal to 1, then R₃ represents an aryl radical or a heterocycle; or

[0030] d) when n is equal to 0 or to 1, then R₁ represents an aryl radical, a heterocycle or a substituted alkyl radical other than a monohydroxyalkyl radical;

[0031] 5) when R₁ and R₂ have the meanings defined in point v), the R₁ and R₂ groups form a heterocycle other than the piperazines and the diazacycloheptanes;

[0032] at least one coupler chosen from heterocyclic couplers, substituted meta-diphenols, substituted meta-phenylenediamines, naphthols and acylated naphthols, and the meta-aminophenols of following formula (II) and their addition salts with an acid:

[0033] in which:

[0034] R₅ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl or C₂-C₄ polyhydroxyalkyl radical,

[0035] R₅ represents a hydrogen atom, a C₁-C₄ alkyl or C₁-C₄ alkoxy radical or a halogen atom chosen from chlorine, bromine or fluorine,

[0036] R₇ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ alkoxy, C₁-C₄ monohydroxyalkyl, C₂-C₄ polyhydroxyalkyl, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical;

[0037] with the proviso that, when R₇ denotes a methyl radical and R₆ denotes a hydrogen atom, then R₅ does not denote a hydrogen atom.

[0038] The dyeing composition in accordance with the invention results in colourings in varied shades which are chromatic, powerful and attractive and which exhibit low selectivity and excellent properties of resistance both with regard to atmospheric agents, such as light and bad weather, and with regard to perspiration and the various treatments which the hair may be subjected to.

[0039] According to a specific embodiment, the oxidation base is chosen from substituted para-phenylenediamine derivatives of following formula (I) and their addition salts with an acid:

[0040] in which:

[0041] R₁ and R₂ can take one of the following meanings i) to v):

[0042] i) R₁ and R₂ simultaneously represent a —(CH₂)₂CHOHCH₂OH radical; or

[0043] ii) R₁ represents a —CH₂(CHOH)₄CH₂OH and R₂ represents a hydrogen atom or an alkyl radical; or

[0044] iv) R₁ represents a —(CH₂CH₂O)_(p)R₄ radical in which p is an integer between 2 and 8 inclusive and R₄ and R₂, which are identical or different, represent a hydrogen atom or an alkyl radical;

[0045] v) R₁ and R₂ form, in conjunction with a nitrogen atom to which they are attached, a saturated 5-, 6- or 7-membered heterocycle, the said heterocycle being substituted by at least one radical comprising at least one carbon or a nitrogen or oxygen atom not situated in the meta position with respect to the nitrogen atom of the heterocycle;

[0046] —R₃ represents a halogen atom, an alkyl or aryl radical, or a heterocycle;

[0047] n is an integer equal to 0, 1 or 2.

[0048] According to one embodiment of the invention, the R₁ and R₂ groups form a heterocycle comprising a single heteroatom, nitrogen, for example a pyrrolidine heterocycle.

[0049] Mention may very particularly be made, among the substituted para-phenylenediamine derivatives of above formula (I), of 1-N,N-bis(3′,4′-dihydroxybutyl)-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-propyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methoxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethoxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-propyloxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-hexyloxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-(1″-N-3″,5″-dimethylpyrazolyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ureido-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-(1″, 3″, 3″-trimethylureido)-para-phenylene-diamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-dimethylamino-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-mercapto-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-n-butylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-n-octylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydrbxybutyl)-3-mercaptoethyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-mercaptoethylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-β-hydroxyethylthio-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methoxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-1-N-(4″-N″-methylpiperidyl)-3-ethoxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyloxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-dimethylamino-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methylthio-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-mercapto-para-phenylenediamine, 1-N-(hexyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-iospropyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isooctyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-hydroxyethyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-mercaptoethyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(phenyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyloxy-para-phenylenediamine, 1-N-(4″-N-methylpiperidyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyloxy-para-phenylenediamine, 4-N-(methyl)-4-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)amino-7-amino-1-methylindole, 1-N-(hydroxyethyloxyethyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine and their addition salts with an acid.

[0050] The oxidation base is preferably chosen from 1-N,N-bis(3′,4′-dihydroxybutyl)-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methyl-para-phenylenediamine, 1-N,N,-bis(3′,4′-dihydroxybutyl)-3-ethyl-para-phenylenediamine, 1-N,N,-bis(3′,4′-dihydroxybutyl)-3-propyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylene- diamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(hexyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(hydroxyethyloxyethyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine and their addition salts with an acid.

[0051] Mention may also very particularly be made of 1-N-(3′,4′-dihydroxybutyl)-5-aminoindoline, 1-(2′-hydroxyethyl)-2-methyl-5-aminoindoline, 1-methyl-2-hydroxymethyl-5-aminoindoline, 6-methyl-2-hydroxy-ethyl-5-aminoindoline, 2-hydroxyethyloxyethyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyloxyethyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl-6-isopropyl-5-aminoindoline, 2-hydroxyethyl-3-methyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyl)-5-aminoindoline, 1-carboxymethyl-2,3,3-trimethyl-5-aminoindoline, 1-methylsulphonamidoethyl-3-methyl-5-aminoindoline, 1-ureidoethyl-6-methoxy-5-aminoindoline, 1-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-5-aminoindoline, 1-N-(2′-mercaptoethyl)-5-aminoindoline, the dimethyl ester 6-amino-1-methyl-1,2,3,4-tetrahydrofuro[2,3,h]quinoline-4-methyl ester of phosphoric acid, 6-amino-1,2,2-trimethyl-4-trimethylsilanyloxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-hexyl-2,2,7-trimethyl-4-mercaptomethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ethoxyethoxyethoxyethoxy-3′,4′-dihydroxybutyl)-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ethylbis(hydroxyethyloxyethyloxyethyloxyethyl))-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 1-(carboxymethyl)-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 1-(hydroxypropyl)-2,2,3-trimethyl-7-methoxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethylxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(mercaptoethyl)-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,7-trimethyl-4-hydroxymethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3-hydroxypropyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyl)-2,2-dimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1,2,2,4,7-pentamethyl-3-hydroxy-1,2,3,4-tetrahydroquinoline , 6-amino-1-(3′-hydroxypropyl)-4-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-4-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2,7-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-2,2,4-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(mercaptoethyl)-2,2,4-trimethyl-7-(2′,3′-dihydroxypropyloxy)-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,7-trimethyl-3-mercaptomethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ureidoethyl)-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-2,2-dimethyl-7-chloro-1,2,3,4-tetrahydroquinoline-1-propylsulphonic acid, 6-amino-1-(4′-pyridinyl)-2,2,7-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,4,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1,7-diisopropyl-2,2-dimethyl-4-trimethylsilanyloxy-1,2,3,4-tetrahydroquinoline, 6-amino-1,2,2,4-tetramethyl-3-hydroxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-bromo-2,2-dimethyl-4-mercapto-7-isopropyloxy-1,2,3,4-tetrahydroquinoline, and their addition salts with an acid.

[0052] Mention may also very particularly be made of 1-(4′-amino-3′-isopropyloxyphenyl)-2,6-dimethylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(hydroxyethyloxy)pyrrolidine, 1-(4′-amino-3′-methylphenyl)-4-hydroxy-2-methylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-amino-3′-phenoxyphenyl)-3-(methylsulphon-amido)pyrrolidine, 3-n-butylpyrrolidine-1-(4′-amino-3′-phenylsulphonic acid), 1-(4′-amino-3′-acetylamino-phenyl)-3-(hydroxymethyl)pyrrolidine, 7-amino-4-(2′-methyl)-pyrrolydinyl-benzofuran, 1-(4′-amino-phenyl)-2-(4″-aminophenoxymethyl)piperidine, 1-(4′-amino-3′-acetylphenyl)-4-hydroxypiperidine, 1-(4′-aminophenyl)-2-(hydroxyethyl)piperidine, 1-(4′-amino-3′-methoxyphenyl)-2,6-di(hydroxymethyl)piperidine, 1-(4′-amino-3′-isopropyloxyphenyl)-2,6-dimethylpiperidine, 1-(4′-amino-3′-isopropylphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-isopropyloxyphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-aminophenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-dimethylaminophenyl)-2-(mercaptoethyloxyethyl)piperidine, 1-(4′-amino-3′-(2′″,4′″-dichloro)anilinophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylphenyl)-2-methylazacycloheptane, 1-(4!-amino-3″-ureidophenyl)-3-hydroxyazacycloheptane, 1-(4′-amino-3′-sulphamoylaminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylthiophenyl)-2,7-dimethylazacycloheptane, 1-N-(4′-hydroxybutyl)-1-N-(hydroxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N-phenyl-1-N-(hydroxyethyloxyethyl)-para-phenylenediamine, 1-N-benzyl-1-N-(hydroxyethyloxyethyloxyethyloxyethyloxyethyl)-3-trimethylsilyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-3-trimethylsilyloxy-para-phenylenediamine, 1-N-ethyl-1-N-(methoxyethyl-oxyethyloxyethyloxyethyloxyethyl)-3-phenoxycarbonylamino-para-phenylenediamine, 1-N-methyl-1-N-(methoxyethyloxyethyloxyethyl)-3-(2′,5′-dioxopyrrolidinyl)-para-phenylenediamine, 1-N-ethyl-1-N-(hydroxy-ethyloxyethyloxyethyl)-3-(4′-pyridinylthio)-para- phenylenediamine, 1-N-propyl-1-N-(hydroxyethyloxyethyloxyethyl)-3-sulphinyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyl)-3-phenoxycarbonyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(methoxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-oxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyl)-3-isopropyloxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-paraphenylenediamine, 1-N,N-bis(methoxyethyloxyethyloxy-ethyloxyethyloxyethyloxyethyloxyethyl)-3-methoxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-3-methyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyloxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyl)-3-mercaptoethyl-para-phenylenediamine, 1-N,N-bis(benzyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylene-diamine and their addition salts with an acid.

[0053] The oxidation base is preferably chosen from 1-(4′-amino-3′-methylphenyl)-3-(hydroxyethyloxy)pyrrolidine, 1-(4′-amino-3′-methylphenyl)-4-hydroxy-2-methylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-amino-3′-phenoxyphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-aminophenyl)-2-(4″-aminophenoxymethyl)piperidine, 1-(4′-aminophenyl)-2-(hydroxyethyl)piperidine, 1-(4′-amino-3′-isopropylphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-aminophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylphenyl)-2-methylazacycloheptane, 1-(4′-amino-3′-ureidophenyl)-3-hydroxyazacycloheptane, 1-N-4′-hydroxybutyl-1-N-(hydroxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, l-N-methyl-1-N-(hydroxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxy-ethyloxyethyloxyethyl)-3-methyl-para-phenylenediamine, 1-N,N-bis(benzyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine and their addition salts with an acid.

[0054] The para-phenylenediamine derivative or derivatives of formula (I) used as oxidation base in the dyeing composition in accordance with the invention preferably represent from 0.0001 to 20% by weight approximately, more preferably from 0.001 to 15% by weight and more preferably still from 0.01 to 10% by weight with respect to the total weight of the composition.

[0055] Mention may more particularly be made, among the meta-aminophenols of above formula (II), of meta-aminophenol, 5-amino-2-methoxyphenol, 5-amino-2-(β-hydroxyethyloxy)phenol, 5-amino-2-methylphenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 5-N-(β-hydroxyethyl)amino-4-methoxy-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-2,4-dimethoxyphenol, 5-(γ-hydroxypropylamino)-2-methylphenol and their addition salts with an acid.

[0056] Use will preferably be made, among the substituted meta-diphenols which can be used as couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (III) and their addition salts with an acid:

[0057] in which:

[0058] R₈ and R₉, which are identical or different, represent a hydrogen atom, a C₁-C₄ alkyl radical or a halogen atom chosen from chlorine, bromine or fluorine; it being understood that at least one of the R₈ and R₉ radicals is other than a hydrogen atom.

[0059] Mention may more particularly be made, among the substituted meta-diphenols of above formula (IIT), of 2-methyl-1,3-dihydroxybenzene, 4-chloro-1,3-dihydroxybenzene, 2-chloro-1,3-dihydroxybenzene and their addition salts with an acid.

[0060] Use will preferably be made, among the substituted meta-phenylenediamines which can be used as couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (IV) and their addition salts with an acid:

[0061] in which:

[0062] R₁₀ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl or C₂-C₄ polyhydroxyalkyl radical;

[0063] R₁₁ and R₁₂, which are identical or different, represent a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical;

[0064] R₁₃ represents a hydrogen atom, a C₁-C₄ alkoxy, C₁-C₄ aminoalkoxy, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical or a 2,4-diaminophenoxyalkoxy radical; it being understood that at least one of the R₁₀ to R₁₃ radicals is other than a hydrogen atom.

[0065] Mention may more particularly be made, among the substituted meta-phenylenediamines of above formula (IV), of 3,5-diamino-1-ethyl-2-methoxybenzene, 3,5-diamino-2-methoxy-1-methylbenzene, 2,4-diamino-1-ethoxybenzene, 1,3-bis(2,4-diaminophenoxy)propane, bis(2,4-diaminophenoxy)methane, 1-(β-aminoethyloxy)-2,4-diaminobenzene, 2-amino-1-(β-hydroxyethyloxy)-4-(methylamino)benzene, 2,4-diamino-1-ethoxy-5-methylbenzene, 2,4-diamino-5-(β-hydroxyethyloxy)-1-methylbenzene, 2,4-diamino-1-(β,γ-dihydroxypropyloxy)-benzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-N-(β-hydroxyethyl)amino-1-methoxybenzene and their addition salts with an acid.

[0066] Mention may in particular be made, among the heterocyclic couplers which can be used in the dyeing composition in accordance with the invention the invention, of indole derivatives, indoline derivatives, benzimidazole derivatives, benzomorpholine derivatives, sesamol derivatives, pyrazoloazole derivatives, pyrroloazole derivatives, imidazoloazole derivatives, pyrazolopyrimidine derivatives, pyrazoline-3,5-dione derivatives, pyrrolo[3,2-d]oxazole derivatives, pyrazolo[3,4-d]thiazole derivatives, thiazoloazole S-oxide derivatives, thiazoloazole S,S-dioxide derivatives and their addition salts with an acid.

[0067] Mention is more particularly made, among the indole derivatives which are used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (V) and their addition salts with an acid:

[0068] in which:

[0069] R₁₄ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl, C₂-C₄ polyhydroxyalkyl or C₁-C₄ aminoalkyl radical, the amine of which is mono- or disubstituted by a C₁-C₄ alkyl group;

[0070] R₁₅ represents a hydrogen atom or a C₁-C₄ alkyl radical;

[0071] R₁₆ represents a hydrogen atom or a C₁-C₄ alkyl or hydroxyl radical;

[0072] X represents a hydroxyl or NHR₁₇ radical in which R₁₇ represents a hydrogen atom or a C₁-C₄ alkyl or C₁-C₄ hydroxyalkyl radical.

[0073] Mention may more particularly be made, among the indole derivatives of above formula (V), of 4-hydroxyindole, 6-hydroxyindole, 7-aminoindole, 6-aminoindole, 7-hydroxyindole, 7-ethyl-6-[(β-hydroxyethyl)amino]indole, 4-aminoindole, 6-hydroxy-1-methylindole, 5,6-dihydroxyindole, 4-hydroxy-1-N-methylindole, 4-hydroxy-2-methylindole, 4-hydroxy-5-methylindole, 4-hydroxy-1-N—(β-hydroxyethyl)indole, 4-hydroxy-1-N-(β-hydroxypropyl)indole, 1-N-(β,γ-dihydroxypropyl)-4-hydroxyindole, 4-hydroxy-1-N-(β-hydroxyethyl)-5-methylindole, 1-N-(γ-dimethylaminopropyl)-4-hydroxyindole and their addition salts with an acid.

[0074] Mention may particularly be made, among the indoline derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of 4-hydroxyindoline, 6-hydroxyindoline, 6-aminoindoline, 5,6-dihydroxyindoline and their addition salts with an acid.

[0075] Mention may more particularly be made, among the benzimidazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (VI) and their addition salts with an acid:

[0076] in which:

[0077] R₁₈ represents a hydrogen atom or a C₁-C₄ alkyl radical,

[0078] R₁₉ represents a hydrogen atom or a C₁-C₄ alkyl or phenyl radical,

[0079] R₂₀ represents a hydroxyl, amino or methoxy radical,

[0080] R₂₁ represents a hydrogen atom or a hydroxyl, methoxy or C₁-C₄ alkyl radical;

[0081] with the proviso that:

[0082] when R₂₀ denotes an amino radical, then it occupies the 4-position,

[0083] when R₂₀ occupies the 4-position, then R₂₁ occupies the 7-position,

[0084] when R₂₀ occupies the 5-position, then R₂₁ occupies the 6-position.

[0085] Mention may more particularly be made, among the benzimidazole derivatives of above formula (VI), of 4-hydroxybenzimidazole, 4-aminobenzimidazole, 4-hydroxy-7-methylbenzimidazole; 4-hydroxy-2-methylbenzimidazole, 1-butyl-4-hydroxybenzimidazole, 4-amino-2-methylbenzimidazole, 5,6-dihydroxybenzimidazole, 5-hydroxy-6-methoxybenzimidazole, 4,7-dihydroxybenzimidazole, 4,7-dihydroxy-1-methylbenzimidazole, 4,7-dimethoxybenzimidazole, 5,6-dihydroxy-1-methylbenzimidazole, 5,6-dihydroxy-1-methylbenzimidazole, 5,6-dimethoxybenzimidazole and their addition salts with an acid.

[0086] Mention may more particularly be made, among the benzomorpholine derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (VII) and their addition salts with an acid:

[0087] in which:

[0088] R₂₂ and R₂₃, which are identical or different, represent a hydrogen atom or a C₁-C₄ alkyl radical,

[0089] Z represents a hydroxyl or amino radical.

[0090] Mention may more particularly be made, among the benzomorpholine derivatives of above formula (VII), of 6-hydroxy-1,4-benzomorpholine, N-methyl-6-hydroxy-1,4-benzomorpholine, 6-amino-1,4-benzomorpholine and their addition salts with an acid.

[0091] Mention may particularly be made, among the sesamol derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (VIII) and their addition salts with an acid:

[0092] in which:

[0093] R₂₄ denotes a hydroxyl, amino, (C₁-C₄)alkylamino, monohydroxy(C₁-C₄)alkylamino or polyhydroxy (C₂-C₄) alkylamino radical,

[0094] R₂₅ denotes a hydrogen or halogen atom or a C₁-C₄ alkoxy radical.

[0095] Mention may more particularly be made, among the sesamol derivatives of above formula (VIII) of 2-bromo-4,5-methylenedioxyphenol, 2-methoxy-4,5-methylenedioxyaniline, 2-(P-hydroxyethyl)amino-4,5-methylenedioxybenzene and their addition salts with an acid.

[0096] Mention may more particularly be made, among the pyrazoloazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in the following patent applications and patents: FR-A-2 075 583, EP-A-0 119 860, EP-A-0 285 274, EP-A-0 244 160, EP-A-0 578 248, GB 1 458 377, U.S. Pat. No. 3,227,554, U.S. Pat. No. 3,419,391, U.S. Pat. No. 3,061,432, U.S. Pat. No. 4,500,630, U.S. Pat. No. 3,725,067, U.S. Pat. No. 3,926,631, U.S. Pat. No. 5,457,210, JP 84/99437, JP 83/42045, JP 84/162548, JP 84/171956, JP 85/33552, JP 85/43659, JP 85/172982 and JP 85/190779, and in the following publications: Chem. Ber., 32, 797 (1899), Chem. Ber., 89, 2550 (1956), J. Chem. Soc. Perkin Trans T., 2047 (1977), J. Prakt. Chem., 320, 533 (1978); the teachings of which form an integral part of the present application.

[0097] Mention may very particularly be made, as pyrazoloazole derivatives, of:

[0098] 2-methylpyrazolo[1,5-b]-1,2,4-triazole,

[0099] 2-ethylpyrazolo[1,5-b],2,4-triazole,

[0100] 2-isopropylpyrazolo[1,5-b]-1,2,4-triazole,

[0101] 2-phenylpyrazolo[1,5-b]-1,2,4-triazole,

[0102] 2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole,

[0103] 7-chloro-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole,

[0104] 3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole,

[0105] 6-phenyl-3-methylthiopyrazolo[3,2-c]-1,2,4-triazole,

[0106] 6-aminopyrazolo[1,5-a]benzimidazole, and their addition salts with an acid.

[0107] Mention may more particularly be made, among the pyrroloazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in the following patent applications and patents: U.S. Pat. No. 5,256,526, EP-A-0 557 851, EP-A-0 578 248, EP-A-0 518 238, EP-A-0 456 226, EP-A-0 488 909 and EP-A-0 488 248, and in the following publications:

[0108] D.R. Liljegren, Ber., 1964, 3436;

[0109] E. J. Browne, J.C.S., 1962, 5149;

[0110] P. Magnus, J.A.C.S., 1990, 112, 2465;

[0111] P. Magnus, J.A.C.S., 1987, 109, 2711;

[0112] Angew. Chem., 1960, 72, 956; and

[0113] Rec. Trav. Chim., 1961, 80, 1075; the teachings of which form an integral part of the present application.

[0114] Mention may very particularly be made, as pyrroloazole derivatives, of:

[0115] 5-cyano-4-ethoxycarbonyl-8-methylpyrrolo[1,2-b]-1,2,4-triazole,

[0116] 5-cyano-8-methyl-4-phenylpyrrolo[!,2-b]-1,2,4-triazole,

[0117] 7-amido-6-ethoxycarbonylpyrrolo[1,2-a]benzimidazole, and their addition salts with an acid.

[0118] Mention may more particularly be made, among the imidazoloazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in the following patent applications and patents: U.S. Pat. No. 5,441,863; JP 62-279 337; JP 06-236 011 and JP 07-092 632, the teachings of which form an integral part of the present application.

[0119] Mention may very particularly be made, as imidazoloazole derivatives, of:

[0120] 7,8-dicyanoimidazolo[3,2-a]imidazole,

[0121] 7,8-dicyano-4-methylimidazolo[3,2-a]imidazole,

[0122] and their addition salts with an acid.

[0123] Mention may more particularly be made, among the pyrazolopyrimidine derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in Patent Application EP-A-0 304 001, the teaching of which forms an integral part of the present application.

[0124] Mention may very particularly be made, as pyrazolopyrimidine derivatives, of: pyrazolo[1,5-a]pyrimidin-7-one,

[0125] 2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-one,

[0126] 2-methyl-6-ethoxycarbonylpyrazolo[1,5-a]pyrimidin-7-one,

[0127] 2-methyl-5-(methoxymethyl)pyrazolo[1,5-a]pyrimidin-7-one,

[0128] 2-tertbutyl-5-trifluoromethylpyrazolo[1,5-a]-pyrimidin-7-one,

[0129] 2,7-dimethylpyrazolo[1,5-a]pyrimidin-5-one,

[0130] and their addition salts with an acid.

[0131] Mention may more particularly be made, among the pyrazoline-3,5-dione derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in the following patent applications and patents: JP 07-036159, JP 07-084348 and U.S. Pat. No. 4,128,425, and in the following publications:

[0132] L. Wyzgowska, Acta. Pol. Pharm., 1982, 39 (1-3), 83

[0133] E. Hannig, Pharmazie, 1980, 35 (4), 231

[0134] M. H. Elnagdi, Bull. Chem. Soc. Jap., 46 (6), 1830, 1973

[0135] G. Cardillo, Gazz. Chim. Ital., 1966, 96 (8-9), 973; the teachings of which form an integral part of the present application.

[0136] Mention may very particularly be made, as pyrazoline-3,5-dione derivatives, of:

[0137] 1,2-diphenylpyrazoline-3,5-dione,

[0138] 1,2-diethylpyrazoline-3,5-dione,

[0139] and their addition salts with an acid.

[0140] Mention may more particularly be made, among the pyrrolo[3,2-d]oxazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in Patent Application JP 07 325 375, the teaching of which forms an integral part of the present application.

[0141] Mention may more particularly be made, among the pyrazolo[3,4-d]thiazole derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in Patent Application JP 07 244 361 and in J. Heterocycl. Chem., 16, 13 (1979).

[0142] Mention may more particularly be made, among the thiazoloazole S-oxide and thiazoloazole S,S-dioxide derivatives which can be used as heterocyclic couplers in the dyeing composition in accordance with the invention, of the compounds disclosed in the following documents:

[0143] JP 07 098489;

[0144] Khim. Geterotsilk. Soedin, 1967, p. 93;

[0145] J. Prakt. Chem., 318, 1976, p. 12;

[0146] Indian J. Heterocycl. Chem., 1995, 5(2), p. 135;

[0147] Acta. Pol. Pharm., 1995, 52(5), 415;

[0148] Heterocycl. Commun., 1995, 1(4), 297;

[0149] Arch. Pharm. (Weinheim, Ger.), 1994, 327(12), 825.

[0150] Use will preferably be made, among the naphthols and acylated naphthols which can be used as couplers in the dyeing composition in accordance with the invention, of the compounds of following formula (IX) and their addition salts with an acid:

[0151] in which:

[0152] R₂₆ represents a hydrogen atom or a —CO—R group in which R represents a C₁-C₄ alkyl radical;

[0153] R₂₇ represents a hydrogen atom, a hydroxyl or C₁-C₄ alkyl radical or an —SO₃H group;

[0154] R₂₈ represents a hydrogen atom or a hydroxyl radical; it being understood that at least one of the R26 to R₂₈ radicals is other than a hydrogen atom.

[0155] Mention may in particular be made, among the naphthols and acylated naphthols of formula (IX) which can be used as couplers in the dyeing composition in accordance with the invention, of 1,7-dihydroxynaphthalene, 2,7-dihydroxynaphthalene, 2,5-dihydroxynaphthalene, 2,3-dihydroxynaphthalene, 1-acetoxy-2-methylnaphthalene, 1-hydroxy-2-methylnaphthalene, 1-hydroxy-4-naphthalenesulphonic acid and their addition salts with an acid.

[0156] The coupler or couplers as defined above according to the invention preferably represent from 0.0001 to 10% by weight approximately of the total weight of the composition and more preferably still from 0.005 to 5% by weight approximately of this weight.

[0157] The dyeing composition in accordance with the invention can, in addition to the coupler or couplers defined above, comprise one or more additional couplers.

[0158] These additional couplers are chosen more particularly from 2-methyl-5-aminophenol, 1,3-dihydroxybenzene or 1,3-diaminobenzene.

[0159] When they are present, the additional coupler or couplers preferably represent from 0.0001 and 8% by weight with respect to the total weight of the composition.

[0160] The dyeing composition in accordance with the invention can moreover include one or more additional oxidation bases other than the substituted para-phenylenediamine derivatives of formula (I) and/or one or more direct dyes.

[0161] Mention may be made, among the additional oxidation bases which can be used in the dyeing composition in accordance with the invention, of para-phenylenediamines other than those of formula (I), such as, for example, para-phenylenediamine, para-tolylenediamine, 2-hydroxyethyl-para-phenylenediamine or 1-N,N-bis(β-hydroxyethyl)-para-phenylenediamine, para-aminophenols, such as, for example, 3-methyl-4-aminophenol and 4-aminophenol, ortho-phenylenediamines, ortho-aminophenols, double bases or heterocyclic bases, such as pyrimidines, like, for example, 2,4,5,6-tetraminopyrimidine, or such as pyrazoles, like, for example, 1-(2-hydroxyethyl)-4,5-diaminopyrazole.

[0162] When they are present, the additional oxidation base or bases represent from 0.0001 and 15% by weight with respect to the total weight of the dyeing composition.

[0163] Generally, the addition salts with an acid which can be used in the context of the dyeing compositions of the invention are chosen in particular from hydrochlorides, hydrobromides, sulphates, tartrates, lactates and acetates.

[0164] The medium appropriate for dyeing (or vehicle) is generally composed of water or of a mixture of water and of at least one organic solvent, in order to dissolve the compounds which would not be sufficiently soluble in water. Mention may be made, for example, as organic solvent, of lower C₁-C₄ alkanols, such as ethanol and isopropanol; glycerol; glycols and glycol ethers, such as 2-butoxyethanol, propylene glycol, propylene glycol monomethyl ether, diethylene glycol monoethyl ether and diethylene glycol monomethyl ether; and aromatic alcohols such as benzyl alcohol or phenoxyethanol, the analogous products and their mixtures.

[0165] The solvents can be present in proportions preferably of between 1 and 40% by weight approximately with respect to the total weight of the dyeing composition and more preferably still between 5 and 30% by weight approximately.

[0166] The pH of the dyeing composition in accordance with the invention is generally between 3 and 12. It can be adjusted to the desired value by means of acidifying or basifying agents commonly used in dyeing keratinous fibres.

[0167] Mention may be made, among acidifying agents, by way of example, of inorganic or organic acids, such as hydrochloric acid, orthophosphoric acid, carboxylic acids, such as tartaric acid, citric acid or lactic acid, or sulphonic acids.

[0168] Mention may be made, among basifying agents, by way of example, of aqueous ammonia, akaline carbonates, alkanolamines, such as mono-, di- and triethanolamines, and their derivatives, hydroxyalkylamines and ethylenediamines, which are oxyethylenated and/or oxypropylenated, sodium hydroxide, potassium hydroxide and the compounds of following formula(X):

[0169] in which R₃₃ is a propylene residue optionally substituted by a hydroxyl group or a C₁-C₄ alkyl radical and R₂₉, R₃₀, R₃₁ and R₃₂, which are identical or different, represent a hydrogen atom or a C₁-C₄ alkyl or C₁-C₄ hydroxyalkyl radical.

[0170] The dyeing composition in accordance with the invention can also include various adjuvants conventionally used in hair dyeing compositions, such as anionic, cationic, nonionic, amphoteric or zwitterionic surface-active agents or their mixtures, anionic, cationic, nonionic, amphoteric or zwitterionic polymers or their mixtures, inorganic or organic thickening agents, reducing or antioxidizing agents, penetration agents, sequestering agents, fragrances, buffers, dispersing agents, conditioning agents, such as, for example, silicones, film-forming agents, preserving agents, opacifying agents, silicone or non-silicone UV screening agents, vitamins or provitamins.

[0171] The reducing or antioxidizing agents can be chosen in particular from sodium sulphite, thioglycolic acid, thiolactic acid, sodium bisulphite, dehydro-ascorbic acid, hydroquinone, 2-methylhydroquinone, tert-butylhydroquinone and homogentisic acid and they are then generally present in amounts which can vary between 0.05 and 1.5% by weight approximately with respect to the total weight of the composition.

[0172] The dyeing composition in accordance with the invention preferably includes at least one nonionic surface-active agent in a proportion preferably varying between 0.1 and 20% by weight approximately with respect to the total weight of the composition and at least one cationic or amphoteric substantive polymer in proportion preferably varying between 0.05 and 10% by weight with respect to the total weight of the composition.

[0173] The dyeing composition in accordance with the invention preferably includes at least one thickening polymer comprising at least one hydrophilic unit and at least one fatty chain in a proportion preferably varying between 0.05 and 10% by weight with respect to the total weight of the composition.

[0174] Of course, a person skilled in the art will take care to choose the optional additional compound or compounds mentioned above so that the advantageous properties intrinsically attached to the dyeing composition according to the invention are not, or not substantially, detrimentally affected by the envisaged addition or additions.

[0175] The dyeing composition in accordance with the invention can be provided in various forms, such as in the form of liquids, creams or gels or in any other form appropriate for carrying out dyeing of keratinous fibres and in particular human hair.

[0176] Another subject-matter of the invention is a process for the oxidation dyeing of keratinous fibres and in particular human keratinous fibres, such as the hair, employing the dyeing composition as defined above.

[0177] According to this process, at least one dyeing composition as defined above is applied to the fibres, the colour being developed at acidic, neutral or alkaline pH using an oxidizing agent which is added only at the time of use to the dyeing composition or which is present in an oxidizing composition applied simultaneously or sequentially in a separate fashion.

[0178] According to a particularly preferred embodiment of the dyeing process according to the invention, the dyeing composition as defined above is mixed, at the time of use, with an oxidizing composition comprising, in a medium appropriate for dyeing, at least one oxidizing agent present in an amount sufficient to develop a colouring. The mixture obtained is subsequently applied to the keratinous fibres and is left to stand for 3 to 50 minutes approximately, preferably 5 to 30 minutes approximately, after which the hair is rinsed, washed with shampoo, rinsed again and dried.

[0179] The oxidizing agent can be chosen from oxidizing agents conventionally used for the oxidation dyeing of keratinous fibres and among which may be mentioned hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts, such as perborates and persulphates, peracids and oxidation enzymes, such as peroxidases, laccases, tyrosinases and oxidoreductases, among which may in particular be mentioned pyranose oxidases, glucose oxidases, glycerol oxidases, lactate oxidases, pyruvate oxidases and uricases, the said enzymes optionally being used in combination with their respective donors.

[0180] The pH of the oxidizing composition including the oxidizing agent as defined above is such that, after mixing with the dye composition, the pH of the resulting composition applied to keratinous fibres preferably varies between 3 and 12 approximately and more preferably still between 5 and 11. It is adjusted to the desired value by means of acidifying or basifying agents commonly used in dyeing keratinous fibres and as defined above.

[0181] The oxidizing composition as defined above can also include various adjuvants conventionally used in hair dyeing compositions and as defined above.

[0182] The composition which is finally applied to keratinous fibres can be provided in various forms, such as in the form of liquids, creams or gels or in any other form appropriate for carrying out dyeing of keratinous fibres and in particular of human hair.

[0183] Another subject-matter of the present invention is a multi-compartment device or multi-compartment dyeing kit or any other packaging system with several compartments, a first compartment of which includes the dyeing composition as defined above and a second compartment of which includes the oxidizing composition as defined above. These devices can be. equipped with a means allowing the desired mixture to be delivered to the hair, such as the devices disclosed in Patent FR-2 586 913 on behalf of the Applicant Company.

[0184] The examples which follow are intended to illustrate the invention.

DYEING EXAMPLES 1 TO 4

[0185] The following dyeing compositions in accordance with the invention were prepared: EXAMPLES 1 2 3 4 1-(4′-Amino-3′- 3 × 10⁻³ 3 × 10⁻³ 3 × 10⁻³ 3 × 10⁻³ methylphenyl)-4- mol mol mol mol hydroxy-2-methylpyrroli- dine dihydrochloride (substituted para-phenyl- enediamine derivative of formula (I) in accordance with the invention) 2,4-Diamino-1-(β- 3 × 10⁻³ — — — hydroxyethyloxy) mol benzene dihydrochloride (coupler) 2-Methyl-1,3-dihydroxy- — 3 × 10⁻³ benzene (coupler) mol 4-Hydroxyindole — — 3 × 10⁻³ — (coupler) mol 1-Naphthol — — — 3 × 10⁻³ mol Common dyeing vehicle (*) (*) (*) (*) Demineralized water, 100 g 100 g 100 g 100 g q.s. for (*) Common dyeing vehicle: C₈-C₁₀ Alkyl polyglucoside as a 60% aqueous 5.4 g solution, sold under the name Oramix CG 110 ® by Seppic Ethanol 18.0 g Benzyl alcohol 1.8 g Polyethylene glycol 400 2.7 g Pentasodium salt of diethylenetriaminepenta- 1.08 g acetic acid as a 40% aqueous solution, sold under the name Dissoluine D-40 ® by Akzo Sodium metabisulphite 0.205 g Aqueous ammonia comprising 20.5% of NH₃ 10.0 g

[0186] At the time of use, the dyeing compositions described above were mixed, weight for weight, with a 20-volume hydrogen peroxide solution (6% by weight).

[0187] The mixtures thus prepared were applied for 30 minutes to locks of permed natural grey hair comprising 90% of white hairs. The locks were subsequently rinsed, washed with a standard shampoo, rinsed again and then dried.

[0188] The hair samples were dyed in the following shades: EXAMPLES Shades obtained 1 Strong blue 2 Strong golden 3 Strong golden coppery 4 Strong blue-grey 

1. Composition for the oxidation dyeing of keratinous fibres and in particular of human keratinous fibres, such as the hair, characterized in that it comprises, in a medium appropriate for dyeing: at least one oxidation base chosen From substituted para-phenylenediamine derivatives of following formula (I) and their addition salts with an acid:

in which: R₁ and R₂ can take one of the following meanings i) to v): i) R₁ and R₂ simultaneously represent a —(CH₂)₂CHOHCH₂OH radical; or ii) R1 represents a —CH₂(CHOH)₄CH₂OH radical and R₂ represents a hydrogen atom, an alkyl or aryl radical or a heterocycle; or iii) R₁ represents an alkyl or aryl radical or a heterocycle and R₂ represents an alkylene radical —(CH₂)_(m)— in which m is an integer equal to 2 or to 3, the said alkylene radical forming a ring in conjunction with the nitrogen atom, the carbon atom of the benzene ring carrying the nitrogen atom and one of the two carbon atoms of the benzene ring which are adjacent to it, it being understood that, when R1 is an alkyl or aryl radical, then either R1 or the said alkylene radical is substituted by a radical comprising at least one nitrogen, oxygen or sulphur atom; iv) R₁ represents a —(CH₂CH₂O)_(p)R₄ radical in which p is an integer between 2 and 8 inclusive and R₄ and R₂, which are identical or different, represent a hydrogen atom, an alkyl or aryl radical or a heterocycle; v) R₁ and R₂ form, in conjunction with the nitrogen atom to which they are attached, a saturated 5-, 6- or 7-membered heterocycle, the said heterocycle being substituted by at least one radical comprising at least one carbon, nitrogen, oxygen or sulphur atom; R₃ represents a halogen atom, an alkyl or aryl radical, a heterocycle, a heterocycle connected to the benzene ring of the formula (I) via an ether or sulphide bond, or a cyano, nitro, hydroxyl, carboxyl, sulpho, alkoxy, aryloxy, cyanoamino, amino, anilino, ureido, sulphamoyl, mono- or dialkyl-sulphamylamino, alkylthio, arylthio, alkoxycarbonyl-amino, sulphonamido, carbamyl, mono- or dialkylcarbamylsulphamyl, alkylsuiphonyl, alkoxycarbonyl, azo, acyloxy, carbamyloxy, mono- or dialkyl-carbamyloxy, silyl, silyloxy, aryloxycarbonylamino, imido, sulphinyl, phosphonyl, aryloxycarbonyl, acyl or mercapto radical; the said alkyl radicals comprising from 1 to 25 carbon atoms and being able to be linear, branched or cyclic and to be substituted by one or more radicals and then to represent a mono- or polyhydroxyalkyl, alkoxyalkyl, aminoalkyl, optionally substituted on the nitrogen atom, carboxyalkyl, alkylcarboxyalkyl, thioalkyl, alkylthioalkyl, cyanoalkyl, trifluoroalkyl, sulphoalkyl, phosphoalkyl or haloalkyl radical;, the said alkoxy radicals comprising from 1 to 25 carbon atoms and being able to be linear, branched or cyclic; the said aryl radicals comprising from 6 to 26 carbon atoms and being able to be substituted by one or more radicals chosen from alkyl, substituted alkyl or alkoxy radicals; the heterocycles being mono- or polycyclic, each ring comprising 3, 4, 5 or 6 ring members and being able to comprise one or more heteroatoms, it being understood that, in the case of polycyclic heterocycles, at least one of the rings comprises at least one heteroatom such as N, O or S; n is an integer between 0 and 4; it being understood that, when n is greater than 1, then the R₃ radicals can be identical or different and can form, with one another, a saturated or unsaturated 3-, 4-, 5- or 6-membered ring; with the proviso that: 1) when R₁ and R₂ have the meanings defined in point v), then the compounds of formula (I) do not comprise more than 3 hydroxyl radicals; 2) when R₁ and R₂ have the meanings defined in point v) and when R₁ and R₂ form a pyrrolidine ring substituted by a carbamoyl radical on the carbon in the position α to the nitrogen atom to which they are attached, then n is other than 0; or else the pyrrolidine ring carries at least two substituents; 3) when R₁ and R₂ have the meanings defined in point v) and when R₂ and R₂ form a pyrrolidine ring substituted by a hydroxymethyl radical on the carbon situated in the α position with respect to the nitrogen atom to which they are attached and when n=0 or 1, then either the said ring carries at least two additional substituents or the said ring comprises only one second substituent other than a hydroxyl radical on the carbon situated in the β position with respect to the nitrogen atom and with respect to the carbon carrying the said hydroxymethyl substituent; or else, when R₁ and R₂ have the meanings defined in point v) and R₁ and R₂ form a pyrrolidine ring substituted by a hydroxymethyl radical on the carbon situated in the α position with respect to the nitrogen atom to which they are attached and when n=1, then R₃ is other than an alkyl or mono- or polyhydroxyalkyl radical; 4) when R₁ and R₂ have the meanings defined in point iii), the compounds of formula (I) must fulfil at least one of the following four conditions: a) whatever the value of n, the alkylene ring formed by the R₂ radical comprises a substituent in addition to the R₁ radical; or b) n is greater than 1; or c) when n is equal to 1, then R₃ represents an aryl radical or a heterocycle; or d) when n is equal to 0 or to 1, then R₁ represents an aryl radical, a heterocycle or a substituted alkyl radical other than a monohydroxyalkyl radical; 5) when R₁ and R₂ have the meanings defined in point v), the R₁ and R₂ groups form a heterocycle other than the piperazines and the diazacycloheptanes; at least one coupler chosen from heterocyclic couplers, substituted meta-diphenols, substituted meta-phenylenediamines, naphthols and acylated naphthols, and the meta-aminophenols of following formula (II) and their addition salts with an acid:

in which: R₅ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl or C₂-C₄ polyhydroxyalkyl radical, R₆ represents a hydrogen atom, a C₁-C₄ alkyl or C₁-C₄ alkoxy radical or a halogen atom chosen from chlorine, bromine or fluorine, R₇ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ alkoxy, C₁-C₄ monohydroxyalkyl, C₂-C₄ polyhydroxyalkyl, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical; with the proviso that, when R₇ denotes a methyl radical and R₆ denotes a hydrogen atom, then R₅ does not denote a hydrogen atom.
 2. Composition according to claim 1, in which the oxidation base is chosen from substituted para-phenylenediamine derivatives of following formula (I) and their addition salts with an acid;

in which: R₁ and R₂ can take one of the following meanings i) to v): i) R₁ and R₂ simultaneously represent a —(CH₂)₂CHOHCH₂OH radical; or ii) R₁ represents a —CH₂(CHOH)₄CH₂OH and R₂ represents a hydrogen atom or an alkyl radical; or iv) R₁ represents a —(CH₂CH₂O)_(p)R₄ radical in which p is an integer between 2 and 8 inclusive and R₄ and R₂, which are identical or different, represent a hydrogen atom or an alkyl radical; v) R₁ and R₂ form, in conjunction with a nitrogen atom to which they are attached, a saturated 5-, 6- or 7-membered heterocycle, the said heterocycle being substituted by at least one radical comprising at least one carbon or a nitrogen or oxygen atom not situated in the meta position with respect to the nitrogen atom of the heterocycle; R₃ represents a halogen atom, an alkyl or aryl radical, or a heterocycle; n is an integer equal to 0, 1 or
 2. 3. Composition according to claim 1 or 2, characterized in that the substituted para-phenylenediamine derivatives of formula (I) are chosen from 1-N,N-bis(3′,4′-dihydroxybutyl)-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-propyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methoxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethoxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-propyloxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-hexyloxy-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-(1″-N-3″,5″-dimethylpyrazolyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ureido-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-(1″,3″,3″-trimethylureido)-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-dimethylamino-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-ethylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-mercapto-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-n-butylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-n-octylthio-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-mercaptoethyl-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-mercaptoethylthio-para-phenylene-diamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-β-hydroxy-ethylthio-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methoxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-1-N-(4″-N″-methylpiperidyl)-3-ethoxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyloxy-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-dimethylamino-para-phenylenediamine, 1-N-(2′,3′,4′,5′, 6′-pentahydroxyhexyl)-3-methylthio-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-mercapto-para-phenylenediamine, 1-N-(hexyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-iospropyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isooctyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyloxy-paraphenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-hydroxyethyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-mercaptoethyloxy-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(phenyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyloxy-para-phenylenediamine, 1-N-(4″-N-methylpiperidyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyloxy-para-phenylenediamine, 4-N-(methyl)-4-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)amino-7-amino-1-methylindole, 1-N-(hydroxyethyloxyethyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine, 1-N-(3′,4′-dihydroxybutyl)-5-aminoindoline, 1-(2′-hydroxyethyl)-2-methyl-5-aminoindoline, 1-methyl-2-hydroxymethyl-5-aminoindoline, 6-methyl-2-hydroxyethyl-5-aminoindoline, 2-hydroxyethyloxyethyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyloxyethyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl-6-isopropyl-5-aminoindoline, 2-hydroxyethyl-3-methyl-5-aminoindoline, 2-hydroxyethyloxyethyloxyethyl)-5-aminoindoline, 1-carboxymethyl-2,3,3-trimethyl-5-aminoindoline, 1-methylsulphonamidoethyl-3-methyl-5-aminoindoline, 1-ureidoethyl-6-methoxy-5-aminoindoine, 1-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-5-aminoindoline, 1-N-(2′-mercaptoethyl)-5-aminoindoline, the dimethyl ester 6-amino-1-methyl-1,2,3,4-tetrahydrofuro[2,3,h]-quinoline-4-methyl ester of phosphoric acid, 6-amino-1,2,2-trimethyl-4-trimethylsilanyloxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-hexyl-2,2,7-trimethyl-4-mercaptomethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ethoxyethoxyethoxyethoxy-3′,4′-dihydroxybutyl)-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ethylbis(hydroxyethyloxyethyloxyethyloxyethyl))-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 1-(carboxymethyl)-2,2,3,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 1-(hydroxypropyl)-2,2,3-trimethyl-7-methoxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxy-thyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2,3-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(mercaptoethyl)-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,3-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,7-trimethyl-4-hydroxymethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3-hydroxypropyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-4-hydroxymethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyl)-2,2-dimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1,2,2,4,7-pentamethyl-3-hydroxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′-hydroxypropyl)-4-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-4,4-dimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-4-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2,7-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(hydroxyethyloxyethyloxyethyloxyethyl)-2,2-dimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-2,2,4-trimethyl-7-isopropyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(mercaptoethyl)-2,2,4-trimethyl-7-(2′,3′-dihydroxypropyloxy)-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,7-trimethyl-3-mercaptomethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(ureidoethyl)-2,2,4-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-2,2-dimethyl-7-chloro-1,2,3,4-tetrahydroquinoline-1-propylsulphonic acid, 6-amino-1-(4′-pyridinyl)-2,2,7-trimethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1-(3′,4′-dihydroxybutyl)-2,2,4,7-tetramethyl-1,2,3,4-tetrahydroquinoline, 6-amino-1,7-diisopropyl-2,2-dimethyl-4-trimethylsilanyloxy-1,2,3,4-tetrahydroquinoline, 6-amino-1,2,2,4-tetramethyl-3-hydroxy-1,2,3,4-tetrahydroquinoline, 6-amino-1-bromo-2,2-dimethyl-4-mercapto-7-isopropyloxy-1,2,3,4-tetrahydroquinoline, 1-(4′-amino-3′-isopropyloxyphenyl)-2,6-dimethylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(hydroxyethyloxy)pyrrolidine, 1-(4′-amino-3′-methylphenyl)-4-hydroxy-2-methylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-amino-3′-phenoxyphenyl)-3-(methylsulphonamido)pyrrolidine, 3-n-butylpyrrolidine-1-(4′-amino-3′-phenylsulphonic acid), 1-(4′-amino-3′-acetylaminophenyl)-3-(hydroxymethyl)pyrrolidine, 7-amino-4-(2′-methyl)-pyrrolydinyl-benzofuran, 1-(4′-aminophenyl)-2-(4″-aminophenoxymethyl)piperidine, 1-(4′-amino-3′-acetylphenyl)-4-hydroxypiperidine, 1-(4′-amino-phenyl)-2-(hydroxyethyl)piperidine, 1-(4′-amino-3′-methoxyphenyl)-2,6-di(hydroxymethyl)piperidine, 1-(4′-amino-3′-isopropyloxyphenyl)-2,6-dimethylpiperidine, 1-(4′-amino-3′-isopropylphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-isopropyloxyphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-amino-phenyl)-2-(hydroxymethyl)piperidine, 1-(4′-amino-3′-dimethylaminophenyl)-2-(mercaptoethyloxyethyl)piperidine, 1-(4′-amino-3′(-2′″,4′″-dichloro)anilinophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylphenyl)-2-methylazacycloheptane, 1-(4′-amino-3′-ureidophenyl)-3-hydroxyazacycloheptane, 1-(4′-amino-3′-sulphamoylaminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylthiophenyl)-2,7-dimethylazacycloheptane, 1-N-(4′-hydroxybutyl)-1-N-(hydroxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N-phenyl-1-N-(hydroxyethyloxyethyl)-para-phenylenediamine, 1-N-benzyl-1-N-(hydroxyethyloxyethyloxyethyloxyethyloxyethyl)-3-trimethylsilyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyloxyethyloxy-ethyloxyethyloxyethyloxyethyloxyethyl)-3-trimethyl-silyloxy-para-phenylenediamine, 1-N-ethyl-1-N-(methoxyethyloxyethyloxyethyloxyethyloxyethyl)-3-phenoxycarbonylamino-para-phenylenediamine, 1-N-methyl-1-N-(methoxyethyloxyethyloxyethyl)-3-(2′,5′-dioxopyrrolidinyl)-para-phenylenediamine, 1-N-ethyl-1-N-(hydroxyethyloxyethyloxyethyl)-3-(4′-pyridinylthio)para-phenylenediamine, 1-N-propyl-1-N-(hydroxyethyloxyethyloxyethyl)-3-sulphinyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyl)-3-phenoxycarbonyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(methoxyethyloxyethyloxyethyloxyethyl)-3-isopropyloxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyl)-3-isopropyloxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(methoxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-3-methoxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-3-methyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyloxy-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyl)-3-mercaptoethyl-para-phenylenediamine, 1-N,N-bis(benzyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine and their addition salts with an acid.
 4. Composition according to any one of the preceding claims, in which the oxidation base is chosen from 1-N,N-bis(3′,4′-dihydroxybutyl)-para-phenylenediamine, 1-N,N-bis(3′,4′-dihydroxybutyl)-3-methyl-para-phenylenediamine, 1-N,N,-bis(3′,4′-dihydroxybutyl)-3-ethyl-para-phenylenediamine, 1-N,N,-bis(3′,4′-di-hydroxybutyl)-3-propyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(hexyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-isopropyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-methyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine, 1-N-(methyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-para-phenylenediamine, 1-N-(hydroxyethyloxyethyl)-1-N-(2′,3′,4′,5′,6′-pentahydroxyhexyl)-3-ethyl-para-phenylenediamine and their addition salts with an acid.
 5. Composition according to any one of claims 1 to 3, in which the oxidation base is chosen from 1-(4′-amino-3′-methylphenyl)-3-(hydroxyethyloxy)pyrrolidine, 1-(4′-amino-3′-methylphenyl)-4-hydroxy-2-methylpyrrolidine, 1-(4′-amino-3′-methylphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-amino-3′-phenoxyphenyl)-3-(methylsulphonamido)pyrrolidine, 1-(4′-aminophenyl)-2-(4″-aminophenoxymethyl)piperidine, 1-(4′-aminophenyl)-2-(hydroxyethyl)piperidine, 1-(4′-amino-3′-isopropylphenyl)-2-(hydroxymethyl)piperidine, 1-(4′-aminophenyl)-4-methylpiperidine, 1-(4′-aminophenyl)-2,7-dimethylazacycloheptane, 1-(4′-amino-3′-methylphenyl)-2-methylazacycloheptane, 1-(4′-amino-3′-ureidophenyl)-3-hydroxyazacycloheptane, 1-N-4′-hydroxybutyl-1-N-(hydroxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N-methyl-1-N-(hydroxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine, 1-N,N-bis(hydroxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyloxyethyl)-3-methyl-para-phenylenediamine, 1-N,N-bis-(benzyloxyethyloxyethyloxyethyl)-3-isopropyl-para-phenylenediamine and their addition salts with an acid.
 6. Composition according to any one of the preceding claims, characterized in that the para-phenylenediamine derivative or derivatives of formula (I) represent from 0.0001 to 20% by weight of the total weight of the composition.
 7. Composition according to claim 1 or 2, characterized in that the R₁ and R₂ groups form a pyrrolidine heterocycle.
 8. Composition according to any one of the preceding claims, characterized in that the meta-aminophenols of formula (II) are chosen from meta-aminophenol, 5-amino-2-methoxyphenol, 5-amino-2-(β-hydroxyethyloxy)phenol, 5-amino-2-methylphenol, 5-N-(β-hydroxyethyl)amino-2-methylphenol, 5-N-(β-hydroxyethyl)amino-4-methoxy-2-methylphenol, 5-amino-4-methoxy-2-methylphenol, 5-amino-4-chloro-2-methylphenol, 5-amino-2,4-dimethoxyphenol, 5-(γ-hydroxypropylamino)-2-methylphenol and their addition salts with an acid.
 9. Composition according to any one of the preceding claims, characterized in that the substituted meta-diphenols are chosen from the compounds of following formula (III) and their addition salts with an acid:

in which: R₈ and R₉, which are identical or different, represent a hydrogen atom, a C₁-C₄ alkyl radical or a halogen atom chosen from chlorine, bromine or fluorine; it being understood that at least one of the R₈ and R₉ radicals is other than a hydrogen atom.
 10. Composition according to claim 9, characterized in that the substituted meta-diphenols of formula (III) are chosen from 2-methyl-1,3-dihydroxybenzene, 4-chloro-1,3-dihydroxybenzene, 2-chloro-1,3-dihydroxybenzene and their addition salts with an acid.
 11. Composition according to any one of the preceding claims, characterized in that the substituted meta-phenylenediamines are chosen from the compounds of following formula (IV) and their addition salts with an acid:

in which: R₁₀ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl or C₂-C₄ polyhydroxyalkyl radical; R₁₁ and R₁₂, which are identical or different, represent a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical; R₁₃ represents a hydrogen atom, a C₁-C₄ alkoxy, C₁-C₄ aminoalkoxy, C₁-C₄ monohydroxyalkoxy or C₂-C₄ polyhydroxyalkoxy radical or a 2,4-diaminophenoxyalkoxy radical; it being understood that at least one of the R10 to R₁₃ radicals is other than a hydrogen atom.
 12. Composition according to claim 7, characterized in that the substituted meta-phenylenediamines of formula (IV) are chosen from 3,5-diamino-1-ethyl-2-methoxybenzene, 3,5-diamino-2-methoxy-1-methylbenzene, 2,4-diamino-1-ethoxybenzene, 1,3-bis(2,4-diaminophenoxy)propane, bis(2,4-diaminophenoxy)methane, 1-(β-aminoethyloxy)-2,4-diaminobenzene, 2-amino-1-(β-hydroxyethyloxy)-4-(methylamino)benzene, 2,4-diamino-1-ethoxy-5-methylbenzene, 2,4-diamino-5-(β-hydroxyethyloxy)-1-methylbenzene, 2,4-diamino-1-(β,γ-dihydroxypropyloxy)benzene, 2,4-diamino-1-(β-hydroxyethyloxy)benzene, 2-amino-4-N—(O-hydroxyethyl)amino-1-methoxybenzene and their addition salts with an acid.
 13. Composition according to any one of the preceding claims, characterized in that the heterocyclic couplers are chosen from indole derivatives, indoline derivatives, benzimidazole derivatives, benzomorpholine derivatives, sesamol derivatives, pyrazoloazole derivatives, pyrroloazole derivatives, imidazoloazole derivatives, pyrazolopyrimidine derivatives, pyrazoline-3,5-dione derivatives, pyrrolo[3,2-d]oxazole derivatives, pyrazolo[3,4-d]thiazole derivatives, thiazoloazole S-oxide derivatives, thiazoloazole S,S-dioxide derivatives and their addition salts with an acid.
 14. Composition according to claim 13, characterized in that the indole derivatives are chosen from the compounds of following formula (V) and their addition salts with an acid:

in which: R₁₄ represents a hydrogen atom or a C₁-C₄ alkyl, C₁-C₄ monohydroxyalkyl, C₂-C₄ polyhydroxyalkyl or C₁-C₄ aminoalkyl radical, the amine of which is mono- or disubstituted by a C₁-C₄ alkyl group; R₁₅ represents a hydrogen atom or a C₁-C₄ alkyl radical; R₁₆ represents a hydrogen atom or a C₁-C₄ alkyl or hydroxyl radical; X represents a hydroxyl or NHR₁₇ radical in which R₁₇ represents a hydrogen atom or a C₁-C₄ alkyl or C₁-C₄ hydroxyalkyl radical.
 15. Composition according to claim 13, characterized in that the indole derivatives of formula (V) are chosen from 4-hydroxyindole, 6-hydroxyindole, 7-aminoindole, 6-aminoindole, 7-hydroxyindole, 7-ethyl-6-[(β-hydroxyethyl)amino]-indole, 4-aminoindole, 6-hydroxy-1-methylindole, 5,6-dihydroxyindole, 4-hydroxy-1-N-methylindole, 4-hydroxy-2-methylindole, 4-hydroxy-5-methylindole, 4-hydroxy-1-N—(β-hydroxyethyl)indole, 4-hydroxy-1-N-(β-hydroxypropyl)indole, 1-N-(β,γ-dihydroxypropyl)-4-hydroxyindole, 4-hydroxy-1-N-(β-hydroxyethyl)-5-methylindole, 1-N-(γ-dimethylaminopropyl)-4-hydroxyindole and their addition salts with an acid.
 16. Composition according to claim 13, characterized in that the indoline derivatives are chosen from 4-hydroxyindoline, 6-hydroxyindoline, 6-aminoindoline, 5,6-dihydroxyindoline and their addition salts with an acid.
 17. Composition according to claim 13, characterized in that the benzimidazole derivatives are chosen from the compounds of following formula (VI) and their addition salts with an acid:

in which: R₁₈ represents a hydrogen atom or a C₁-C₄ alkyl radical, R₁₉ represents a hydrogen atom or a C₁-C₄ alkyl or phenyl radical, R₂₀ represents a hydroxyl, amino or methoxy radical, R₂₁ represents a hydrogen atom or a hydroxyl, methoxy or C₁-C₄ alkyl radical; with the proviso that: when R₂₀ denotes an amino radical, then it occupies the 4-position, when R₂₀ occupies the 4-position, then R₂₁ occupies the 7-position, when R₂₀ occupies the 5-position, then R₂₁ occupies the 6-position.
 18. Composition according to claim 17, characterized in that the benzimidazole derivatives of formula (VI) are chosen from 4-hydroxybenzimidazole, 4-aminobenzimidazole, 4-hydroxy-7-methylbenzimidazole, 4-hydroxy-2-methylbenzimidazole, 1-butyl-4-hydroxybenzimidazole, 4-amino-2-methylbenzimidazole, 5,6-dihydroxybenzimidazole, 5-hydroxy-6-methoxybenzimidazole, 4,7-dihydroxybenzimidazole, 4,7-dihydroxy-1-methylbenzimidazole, 4,7-dimethoxybenzimidazole, 5,6-dihydroxy-1-methylbenzimidazole, 5,6-dihydroxy-2-methylbenzimidazole, 5,6-dimethoxybenzimidazole and their addition salts with an acid.
 19. Composition according to claim 13, characterized in that the benzomorpholine derivatives are chosen from the compounds of following formula (VII) and their addition salts with an acid:

in which: R₂₂ and R₂₃, which are identical or different, represent a hydrogen atom or a C₁-C₄ alkyl radical, Z represents a hydroxyl or amino radical.
 20. Composition according to claim 19, characterized in that the benzomorpholine derivatives of formula (VII) are chosen from 6-hydroxy-1,4-benzomorpholine, N-methyl-6-hydroxy-1,4-benzomorpholine, 6-amino-1,4-benzomorpholine and their addition salts with an acid.
 21. Composition according to claim 13, characterized in that the sesamol derivatives are chosen from the compounds of following formula (VIII) and their addition salts with an acid:

in which: R₂₄ denotes a hydroxyl, amino, (C₁-C₄)alkylamino, monohydroxy(C₁-C₄)alkylamino or polyhydroxy (C₂-C₄) alkylamino radical, R₂₅ denotes a hydrogen or halogen atom or a C₁-C₄ alkoxy radical.
 22. Composition according to claim 21, characterized in that the sesamol derivatives of formula (VIII) are chosen from 2-bromo-4,5-methylenedioxyphenol, 2-methoxy-4,5-methylenedioxyaniline, 2-(β-hydroxyethyl)amino-4,5-methylenedioxybenzene and their addition salts with an acid.
 23. Composition according to claim 13, characterized in that the pyrazoloazole derivatives are chosen from 2-methylpyrazolo[1,5-b]-1,2,4-triazole, 2-ethylpyrazolo[1,5-b]-1,2,4-triazole, 2-isopropyl-pyrazolo[1,5-b]-1,2,4-triazole, 2-phenylpyrazolo[1,5-b]-1,24-triazole, 2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole, 7-chloro-2,6-dimethylpyrazolo[1,5-b]-1,2,4-triazole, 3,6-dimethylpyrazolo[3,2-c]-1,2,4-triazole, 6-phenyl-3-methylthiopyrazolo[3,2-c]-1,2,4-triazole, 6-aminopyrazolo[1,5-a]benzimidazole and their addition salts with an acid.
 24. Composition according to claim 13, characterized in that the pyrroloazole derivatives are chosen from 5-cyano-4-ethoxycarbonyl-8-methylpyrrolo-[1,2-b]-1,2,4-triazole, 5-cyano-8-methyl-4-phenylpyrrolo[1,2-b]-1,2,4-triazole, 7-amido-6-ethoxycarbonylpyrrolo[1,2-a]benzimidazole and their addition salts with an acid.
 25. Composition according to claim 13, characterized in that the imidazoloazole derivatives are chosen from 7,8-dicyanoimidazolo[3,2-a]imidazole, 7,8-dicyano-4-methylimidazolo[3,2-a]imidazole and their addition salts with an acid.
 26. Composition according to claim 13, characterized in that the pyrazolopyrimidine derivatives are chosen from pyrazolo[1,5-a]pyrimidin-7-one, 2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-one, 2-methyl-6-ethoxycarbonylpyrazolo[1,5-a]pyrimidin-7-one, 2-methyl-5-(methoxymethyl)pyrazolo[1,5-a]-pyrimidin-7-one, 2-tertbutyl-5-trifluoromethylpyrazolo[1,5-a]pyrimidin-7-one, 2,7-dimethylpyrazolo-[1,5-a]pyrimidin-5-one and their addition salts with an acid.
 27. Composition according to claim 13, characterized in that the pyrazoline-3,5-dione derivatives are chosen from 1,2-diphenylpyrazoline-3,5-dione, 1,2-diethylpyrazoline-3,5-dione and their addition salts with an acid.
 28. Composition according to claim 13, characterized in that the naphthols and acylated naphthols are chosen from the compounds of following formula (IX) and their addition salts with an acid:

in which: R₂₆ represents a hydrogen atom or a —CO—R group in which R represents a C₁-C₄ alkyl radical; R₂₇ represents a hydrogen atom, a hydroxyl or C₁-C₄ alkyl radical or an —SO₃H group; R₂₈ represents a hydrogen atom or a hydroxyl radical; it being understood that at least one of the R₂₆ to R₂₈ radicals is other than a hydrogen atom.
 29. Composition according to claim 28, characterized in that the naphthols and acylated naphthols of formula (IX) are chosen from 1,7-dihydroxynaphthalene, 2,7-dihydroxynaphthalene, 2,5-dihydroxynaphthalene, 2,3-dihydroxynaphthalene, 1-acetoxy-2-methylnaphthalene, 1-hydroxy-2-methylnaphthalene, 1-hydroxy-4-naphthalenesulphonic acid and their addition salts with an acid.
 30. Composition according to any one of the preceding claims, characterized in that the coupler or couplers as defined in any one of claims 1 and 5 to 26 represent from 0.0001 to 10% by weight of the total weight of the composition.
 31. Composition according to any one of the preceding claims, characterized in that it includes an additional coupler chosen from 2-methyl-5-aminophenol, 1,3-dihydroxybenzene or 1,3-diaminobenzene.
 32. Composition according to any one of the preceding claims, characterized in that it includes one or more additional oxidation bases other than the substituted para-phenylenediamine derivatives of formula (I) as defined in claim 1 or 2 and chosen from para-phenylenediamine, para-tolylenediamine, 2-hydroxyethyl-para-phenylenediamine, 1-N,N-bis(β-hydroxyethyl)-para-phenylenediamine, para-aminophenols, ortho-phenylenediamines, ortho-aminophenols, double bases and heterocyclic bases.
 33. Composition according to any one of the preceding claims, characterized in that the addition salts with an acid are chosen from hydrochlorides, hydrobromides, sulphates, tartrates, lactates and acetates.
 34. Process for the oxidation dyeing of keratinous fibres and in particular human keratinous fibres, such as the hair, characterized in that at least one dyeing composition as defined in any one of claims 1 to 33 is applied to the said fibres, the colour being developed at acidic, neutral or alkaline pH using an oxidizing agent which is added only at the time of use to the dyeing composition or which is present in an oxidizing composition applied simultaneously or sequentially in a separate fashion.
 35. Process according to claim 33, characterized in that the oxidizing agent is chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts, peracids and oxidation enzymes.
 36. Multi-compartment device or multi-compartment dyeing kit, a first compartment of which includes a dyeing composition as defined in any one of claims 1 to 33 and a second compartment of which includes an oxidizing composition. 